Saltar al contenido
Merck

bFGF enhances the development of the collateral circulation after acute arterial occlusion.

Biochemical and biophysical research communications (1992-06-15)
J O Chleboun, R N Martins, C A Mitchell, T V Chirila
RESUMEN

An adequate collateral circulation is crucial to tissue survival subsequent to proximal major arterial occlusion. The precise mechanism of collateral blood vessel development and the biochemical mediators involved in this process are unknown. To evaluate the influence of a number of agents on the development of the collateral circulation, we developed a rat model of severe hind limb ischaemia. The recovery of blood flow after acute arterial occlusion was increased by exogenous basic fibroblast growth factor and heparin, and decreased by protamine. Erucamide (cis-13-docosenamide), an angiogenic lipid, had no effect on collateral blood flow. These results indicate that basic fibroblast growth factor and heparin are potential therapeutic agents in the treatment of peripheral vascular disease.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
cis-13-Docosenoamide